Tag: GSK

Experimental GSK drug achieves functional hepatitis B cure in 1 in 5 patients

GSK's experimental drug bepirovirsen achieved functional hepatitis B cure in 18% of patients during phase 2 trials, vastly outperforming current…

Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network